Literature DB >> 12946021

Neural stem cells: a potential source for remyelination in neuroinflammatory disease.

Lou Brundin1, Hjalmar Brismar, Alexandre I Danilov, Tomas Olsson, Clas B Johansson.   

Abstract

In multiple sclerosis, the central nervous system is lesioned through invasion of plaque-forming inflammatory cells, primarily contributing to immune attack of myelin and oligodendrocytes. In this report we address the possible activation and differentiation of central nervous system stem cells following such immunological insults in a well-characterized rat model of multiple sclerosis characterised by spinal cord pathology. Dye-labeled central nervous system stem cells, residing within the ependymal layer of the central canal responded to the multiple sclerosis-like conditions by proliferation, while some of the migrating stem cell-derived cells expressed markers typical for oligodendrocytes (04) and astrocytes (glial fibrillary acidic protein, GFAP) in the demyelinated area. Our results indicate that regenerative stem cell activation following immunoactivity is different from that after trauma, exemplified by the slower time course of stem cell proliferation and migration of progeny, in addition to the ability of the stem cell-derived cells to express oligodendrocyte markers. Finally, deleterious effects of macrophages on the stem cell population were evident and may contribute to the depletion of the stem cell population in neuroinflammatory disorders.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12946021     DOI: 10.1111/j.1750-3639.2003.tb00031.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  9 in total

1.  Macroglial plasticity and the origins of reactive astroglia in experimental autoimmune encephalomyelitis.

Authors:  Fuzheng Guo; Yoshiko Maeda; Joyce Ma; Monica Delgado; Jiho Sohn; Laird Miers; Emily Mills Ko; Peter Bannerman; Jie Xu; Yazhou Wang; Chengji Zhou; Hirohide Takebayashi; David Pleasure
Journal:  J Neurosci       Date:  2011-08-17       Impact factor: 6.167

2.  Endogenous Nkx2.2+/Olig2+ oligodendrocyte precursor cells fail to remyelinate the demyelinated adult rat spinal cord in the absence of astrocytes.

Authors:  Jason F Talbott; David N Loy; Ying Liu; Mengsheng S Qiu; Mary Bartlett Bunge; Mahendra S Rao; Scott R Whittemore
Journal:  Exp Neurol       Date:  2005-03       Impact factor: 5.330

Review 3.  [Multiple sclerosis: potential therapeutic options and update of ongoing studies].

Authors:  H Wiendl; H C Lehmann; R Hohlfeld; H-P Hartung; B C Kieseier
Journal:  Nervenarzt       Date:  2004-06       Impact factor: 1.214

4.  Human neural stem cells migrate along the nigrostriatal pathway in a primate model of Parkinson's disease.

Authors:  Kimberly B Bjugstad; Yang D Teng; D Eugene Redmond; John D Elsworth; Robert H Roth; Shannon K Cornelius; Evan Y Snyder; John R Sladek
Journal:  Exp Neurol       Date:  2008-02-14       Impact factor: 5.330

5.  Neurotrophin 3 transduction augments remyelinating and immunomodulatory capacity of neural stem cells.

Authors:  Jingxian Yang; Yaping Yan; Yang Xia; Tingguo Kang; Xing Li; Bogoljub Ciric; Hui Xu; Abdolmohamad Rostami; Guang-Xian Zhang
Journal:  Mol Ther       Date:  2013-10-17       Impact factor: 11.454

6.  Human umbilical cord blood-derived mesenchymal stem cell therapy promotes functional recovery of contused rat spinal cord through enhancement of endogenous cell proliferation and oligogenesis.

Authors:  Sang In Park; Jung Yeon Lim; Chang Hyun Jeong; Seong Muk Kim; Jin Ae Jun; Sin-Soo Jeun; Won Il Oh
Journal:  J Biomed Biotechnol       Date:  2012-02-13

Review 7.  Feasibility of cell therapy in multiple sclerosis: a systematic review of 83 studies.

Authors:  Abdolreza Ardeshiry Lajimi; Majid Farshdousti Hagh; Najmaldin Saki; Esmaeil Mortaz; Masoud Soleimani; Fakher Rahim
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2013

Review 8.  Heterogeneous populations of neural stem cells contribute to myelin repair.

Authors:  Rainer Akkermann; Felix Beyer; Patrick Küry
Journal:  Neural Regen Res       Date:  2017-04       Impact factor: 5.135

9.  Emerging stem cell therapies: treatment, safety, and biology.

Authors:  Joel Sng; Thomas Lufkin
Journal:  Stem Cells Int       Date:  2012-08-02       Impact factor: 5.443

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.